Antares Pharma Stock Soars After $960 Million Halozyme Buyout

Barron's2022-04-13

Shares of Antares Pharma surged 49% Wednesday after the specialty pharmaceutical company agreed to be bought by Halozyme Therapeutics in a cash deal valued at $960 million.Under terms of the deal, ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Terri1
    2022-04-14
    Terri1
    Need a crystal ball to predict the buyouts😂
  • Jjvfkjvh
    2022-04-13
    Jjvfkjvh
    Go
  • Lormeetay
    2022-04-13
    Lormeetay
    Buy
Leave a comment
3